|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
493
|
Wed, 8/5/09, 2:00 PM - 3:50 PM | CC-202B |
| Issues in Translating Innovative Phase I Designs Into Oncology Trials - Invited - Papers | ||
|
Biopharmaceutical Section, International Chinese Statistical Association |
||
| Organizer(s): William L. Mietlowski, Novartis Oncology | ||
| Chair(s): William L. Mietlowski, Novartis Oncology | ||
| 2:05 PM |
Translation of Innovative Designs Into Cancer Phase I Trials —  Andre Rogatko, Cedars-Sinai Medical Center
|
|
| 2:30 PM |
Challenges in the Implementation of Adaptive Phase I Clinical Trial Designs for Biologic Agents and Molecularly Targeted Therapies — Daniel Sargent, Mayo Clinic; Sumithra Mandrekar, Mayo Clinic; Rui Qin, Mayo Clinic
|
|
| 2:55 PM |
Ups and Downs of Implementing BLR-EWOC Guided Dose Escalation at Novartis Oncology — Jyotirmoy Dey, Novartis Pharmaceuticals
|
|
| 3:20 PM | Disc: Michael Brave, FDA | |
| 3:40 PM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |